HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Budget Request Signals Importance Of Boosting Food Safety Programs

Executive Summary

"You begin to see FDA telegraphing that this is important. That was lacking in the past two budgets," said Mike Greene, Council for Responsible Nutrition's chief congressional liaison. White House's budget request recommends $67m increase from FY 2019 to $1.4bn for FDA's food industry programs in CFSAN, which includes the Office of Dietary Supplement Programs, and for the Office of Regulatory Affairs' related field activities.

You may also be interested in...



Medical Association's Diagnosis Of US Supplement Market Has Industry Asking For Second Opinion

AMA decides “to call for more stringent federal regulation of supplements—including increased oversight of manufacturing, marketing, product labeling, and adverse event reporting.” But NPA CEO Daniel Fabricant says supplements account for a fraction of the problems linked to drugs approved for sale in the US. "We don’t have a vitamin C crisis in America, we do have an opioid crisis."

US FDA Sets Rates For FSMA User Fees It Won’t Collect In FY 2021: Re-inspections, Recalls

Announcing rates for user fees authorized by Food Safety Modernization Act, FDA says supplement and food firms would be charged $263 an hour should agency officials need to re-inspect a US facility in FY 2021 and $310 an hour for facilities in other countries. Without a guidance for small businesses to request lower rates, the fees won't be imposed.

FDA Clearing CBD As Dietary Ingredient? Legislation More Likely Than Rulemaking

Senate Appropriations subcommittee members add to Capitol Hill's push for FDA to change its current regulatory stance that CBD is deemed noncompliant for use in supplements and food. Commissioner Gottlieb suggests legislation authorizing FDA to allow use of CBD up to certain concentrations in supplements and food products. FDA currently allows sales of food and supplements containing CBD under enforcement discretion.

Related Content

Topics

UsernamePublicRestriction

Register

OM002409

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel